Boryung Corporation (KRX:003850)

Market Cap	705.41B -0.7%
Revenue (ttm)	1.03T +0.8%
Net Income	105.39B +126.3%
EPS	1,267.60 +101.0%
Shares Out	84.48M
PE Ratio	6.59
Forward PE	10.82
Dividend	100.00 (1.20%)
Ex-Dividend Date	Dec 29, 2025

Volume	97,802
Open	8,010.00
Previous Close	8,350.00
Day's Range	7,930.00 - 8,200.00
52-Week Range	7,970.00 - 10,800.00
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 1,533
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003850

Financial Performance

In 2025, Boryung's revenue was 1.02 trillion, an increase of 0.03% compared to the previous year's 1.02 trillion. Earnings were 64.30 billion, a decrease of -7.65%.